Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
The Patient|May 2, 2020
Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIVLouis S Matza, Trena M Paulus, Cindy P Garris, et al.Journal of Medical Economics|October 3, 2022
The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United StatesMichele A Kohli, Michael Maschio, Amy Lee, et al.Infectious Diseases and Therapy|April 15, 2025
Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United StatesKeya Joshi, Mariia Dronova, Ewelina Paterak, et al.Journal of Medical Economics|December 5, 2023
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in GermanyKeya Joshi, Stefan Scholz, Michael Maschio, et al.Vaccines|April 27, 2024
The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in JapanKelly Fust, Keya Joshi, Ekkehard Beck, et al.Journal of Medical Economics|November 14, 2023
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United StatesMichele A Kohli, Michael Maschio, Keya Joshi, et al.Plos One|February 2, 2021
Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling studyBen Parker, Tom Ward, Olivia Hayward, et al.Journal of Medical Economics|June 19, 2024
Vaccine preparation time, errors, satisfaction, and preference of prefilled syringes versus RSV vaccines requiring reconstitution: randomized, time and motion studyDarshan Mehta, Samantha Kimball-Carroll, Dayna R Clark, et al.Infectious Diseases and Therapy|June 25, 2024
Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US AdultsTianyu Sun, Linwei Li, Katherine E Mues, et al.Vaccine|June 9, 2023
Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemicErin Roberts-McCarthy, Philip O Buck, Renae L Smith-Ray, et al.Pageof 6